# CABAZITAXEL
> **NDA208715** · New Drug Application · Sponsor: SANDOZ · Approved 2023-10-27
## Drug
- **FDA Application Number:** NDA208715
- **Application type:** New Drug Application
- **Brand name:** CABAZITAXEL
- **Generic name:** Cabazitaxel
- **Active ingredients:** CABAZITAXEL
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SANDOZ
- **First approval:** 2023-10-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208715)
---
*MORVS · CC0 1.0*